SCHEMBL6003055

SCHEMBL6003055

CCc1scc2cc(F)ccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 1/20 0.33
PPM1A P35813 3/20 0.32
MAPT P10636 3/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SREBF2 Q12772 1/20 0.32
TSHR P16473 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
DCK P27707 1/20 0.30
DRD4 P21917 1/20 0.30
GPR84 Q9NQS5 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002285 0.85 MAPT (0.34) CYP1A2CYP2A6PPM1AMAPTNPC1
SCHEMBL2097025 0.81 CYP1A2 (0.33) CYP1A2CYP2A6MAPTALDH1A1GPR84
SCHEMBL6002741 0.78 CYP2A6 (0.38) CYP2A6MAPTNPC1RAB9ASREBF2
SCHEMBL2092452 0.75 CYP1A2 (0.37) CYP1A2CYP2A6MAPTALDH1A1KDM4E
SCHEMBL2090417 0.72 CYP2A6 (0.38) CYP1A2CYP2A6MAPTTSHRALDH1A1
SCHEMBL27212341 0.69 CYP1A2 (0.35) CYP1A2CYP2A6MAPTNPC1ALDH1A1
SCHEMBL14048575 0.67 MTNR1A (0.46) CYP2A6MAPTMTNR1AMTNR1BALDH1A1
SCHEMBL17232438 0.67 KDM4E (0.39) CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL2089506 0.67 CYP1A2 (0.33) CYP1A2CYP2A6MTNR1AMTNR1BGPR84
SCHEMBL7657320 0.65 CYP1A2 (0.50) CYP1A2CYP2A6NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed